BTG PLC - Aquired

BTG.LSStocksPharmaceuticals MajorUnited KingdomLSEGBP

Price

£8.39

Today

+0.0%

YTD

+0.0%

About

BTG plc dates back to 1948 and is a pharmaceutical company with a portfolio of interventional medicine products, designed to advance the treatment of cancer, vascular conditions and severe emphysema. BTG’s Pharmaceuticals business provides products that help patients overexposed to certain medications or toxins, and its technology helps physicians treat their patients through minimally invasive procedures. In 2018 the company reported £620.5 million in revenue. Follow and trade BTG.L for more news and updates.

Price chart

Closing price history for BTG.LS (1D candles).

No daily candle data is currently available for this instrument.

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)38.51

P/S (TTM)Unknown

P/B (TTM)3.08

Market cap$3.26B

Cap tierMid-cap

Industry avg P/E-7.44

Profitability

Gross margin64.17%

EBIT margin22.71%

Net marginUnknown

ROE8.56%

ROA6.89%

Earnings & Revenue

Revenue (TTM)$695.78M

Revenue growth (1Y)+12.1%

EPS (TTM)$0.22

Free cash flow$95.04M

Total debt$0.00

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.23

Employees1,724

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.